• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Quinolones induce partial or total loss of pathogenicity islands in uropathogenic Escherichia coli by SOS-dependent or -independent pathways, respectively.喹诺酮类药物分别通过SOS依赖或非依赖途径诱导尿路致病性大肠杆菌中致病岛部分或完全缺失。
Antimicrob Agents Chemother. 2006 Feb;50(2):649-53. doi: 10.1128/AAC.50.2.649-653.2006.
2
Are quinolone-resistant uropathogenic Escherichia coli less virulent?耐喹诺酮的尿路致病性大肠杆菌毒力更低吗?
J Infect Dis. 2002 Oct 1;186(7):1039-42. doi: 10.1086/342955. Epub 2002 Sep 13.
3
In vitro activity of prulifloxacin against Escherichia coli isolated from urinary tract infections and the biological cost of prulifloxacin resistance.普卢利沙星对从尿路感染分离出的大肠杆菌的体外活性及普卢利沙星耐药的生物学代价。
Int J Antimicrob Agents. 2007 Jun;29(6):679-87. doi: 10.1016/j.ijantimicag.2007.01.009. Epub 2007 Mar 23.
4
Quinolone-resistant uropathogenic Escherichia coli strains from phylogenetic group B2 have fewer virulence factors than their susceptible counterparts.来自B2系统发育群的耐喹诺酮尿路致病性大肠杆菌菌株比其敏感菌株具有更少的毒力因子。
J Clin Microbiol. 2005 Jun;43(6):2962-4. doi: 10.1128/JCM.43.6.2962-2964.2005.
5
The influence of the SOS response on the activity of 4-quinolones and zidovudine against some strains of Enterobacteria.SOS反应对4-喹诺酮类药物和齐多夫定针对某些肠杆菌菌株活性的影响。
New Microbiol. 1998 Jan;21(1):31-40.
6
Virulence and antimicrobial resistance profiles among Escherichia coli strains isolated from human and animal wastewater.从人类和动物废水中分离出的大肠杆菌菌株的毒力和抗菌药物耐药性特征。
Res Microbiol. 2008 May;159(4):288-93. doi: 10.1016/j.resmic.2008.02.001. Epub 2008 Mar 7.
7
Influence of pathogenicity islands and the minor leuX-encoded tRNA5Leu on the proteome pattern of the uropathogenic Escherichia coli strain 536.致病岛和次要的leuX编码的tRNA5Leu对尿路致病性大肠杆菌菌株536蛋白质组模式的影响。
Int J Med Microbiol. 2000 Mar;290(1):75-84. doi: 10.1016/S1438-4221(00)80110-1.
8
Effects of subinhibitory concentrations of amikacin and ciprofloxacin on the hydrophobicity and adherence to epithelial cells of uropathogenic Escherichia coli strains.亚抑菌浓度的阿米卡星和环丙沙星对尿路致病性大肠杆菌菌株疏水性及黏附上皮细胞的影响。
Int J Antimicrob Agents. 2007 Jun;29(6):700-4. doi: 10.1016/j.ijantimicag.2007.01.007. Epub 2007 Mar 26.
9
Diverse phenotypic and genotypic characterization among clinical Klebsiella pneumoniae and Escherichia coli isolates carrying plasmid-mediated quinolone resistance determinants.携带质粒介导喹诺酮类耐药决定因子的临床肺炎克雷伯菌和大肠埃希菌分离株的表型和基因型特征多样化。
Microb Drug Resist. 2011 Sep;17(3):363-7. doi: 10.1089/mdr.2011.0034. Epub 2011 May 12.
10
Decreased prevalence of virulence factors among ciprofloxacin-resistant uropathogenic Escherichia coli isolates.耐环丙沙星的尿路致病性大肠杆菌分离株中致病因子的流行率降低。
J Clin Microbiol. 2005 Aug;43(8):4218-20. doi: 10.1128/JCM.43.8.4218-4220.2005.

引用本文的文献

1
Distribution of Fimbrial Genes and Their Association with Virulence and Levofloxacin Resistance/Extended-Spectrum Beta-Lactamase Production in Uropathogenic .尿道致病性大肠杆菌中菌毛基因的分布及其与毒力和左氧氟沙星耐药性/超广谱β-内酰胺酶产生的关联
Antibiotics (Basel). 2025 May 6;14(5):468. doi: 10.3390/antibiotics14050468.
2
Resistant Escherichia coli isolated from wild mammals from two rescue and rehabilitation centers in Costa Rica: characterization and public health relevance.从哥斯达黎加两个救援和康复中心的野生哺乳动物中分离出的耐药大肠杆菌:特征描述及公共卫生相关性。
Sci Rep. 2024 Apr 5;14(1):8039. doi: 10.1038/s41598-024-57812-6.
3
Genotypic Characterization of Uropathogenic from Companion Animals: Predominance of ST372 in Dogs and Human-Related ST73 in Cats.伴侣动物尿路致病性大肠杆菌的基因型特征:犬中ST372占优势,猫中与人相关的ST73占优势。
Antibiotics (Basel). 2023 Dec 30;13(1):38. doi: 10.3390/antibiotics13010038.
4
Metabolic and Morphotypic Trade-Offs within the Eco-Evolutionary Dynamics of Escherichia coli.大肠杆菌生态进化动力学中的代谢与形态权衡
Microbiol Spectr. 2022 Oct 26;10(5):e0067822. doi: 10.1128/spectrum.00678-22. Epub 2022 Sep 28.
5
Characterization of Escherichia coli isolated from urinary tract infection and association between virulence expression and antimicrobial susceptibility.从尿路感染中分离的大肠杆菌的特性及其毒力表达与抗菌药物敏感性的关系。
BMC Microbiol. 2022 Apr 6;22(1):89. doi: 10.1186/s12866-022-02506-0.
6
Virulence factors and antimicrobial resistance of uropathogenic Escherichia coli (UPEC) isolated from urinary tract infections: a systematic review and meta-analysis.从尿路感染中分离出的尿路致病性大肠杆菌(UPEC)的毒力因子和抗菌药物耐药性:一项系统综述和荟萃分析
BMC Infect Dis. 2021 Aug 4;21(1):753. doi: 10.1186/s12879-021-06435-7.
7
Regulatory mechanisms of sub-inhibitory levels antibiotics agent in bacterial virulence.亚抑菌浓度抗生素制剂对细菌毒力的调控机制
Appl Microbiol Biotechnol. 2021 May;105(9):3495-3505. doi: 10.1007/s00253-021-11291-1. Epub 2021 Apr 24.
8
Antibiotic resistance pattern and phylogenetic groups of the uropathogenic isolates from urinary tract infections in Hamedan, west of Iran.伊朗西部哈马丹尿路感染患者中尿路致病性分离株的抗生素耐药模式及系统发育组
Iran J Microbiol. 2020 Oct;12(5):388-394. doi: 10.18502/ijm.v12i5.4598.
9
Nitrofurantoin Combined With Amikacin: A Promising Alternative Strategy for Combating MDR Uropathogenic .硝基呋喃妥因联合阿米卡星:治疗多重耐药泌尿道感染的有前途的替代策略
Front Cell Infect Microbiol. 2020 Dec 21;10:608547. doi: 10.3389/fcimb.2020.608547. eCollection 2020.
10
Distribution of genes encoding adhesins and biofilm formation capacity among Uropathogenic isolates in relation to the antimicrobial resistance.与抗菌药物耐药性相关的尿源性分离株中黏附素编码基因的分布和生物膜形成能力。
Afr Health Sci. 2020 Mar;20(1):238-247. doi: 10.4314/ahs.v20i1.29.

本文引用的文献

1
Quinolone-resistant uropathogenic Escherichia coli strains from phylogenetic group B2 have fewer virulence factors than their susceptible counterparts.来自B2系统发育群的耐喹诺酮尿路致病性大肠杆菌菌株比其敏感菌株具有更少的毒力因子。
J Clin Microbiol. 2005 Jun;43(6):2962-4. doi: 10.1128/JCM.43.6.2962-2964.2005.
2
Instability of pathogenicity islands in uropathogenic Escherichia coli 536.尿路致病性大肠杆菌536中致病岛的不稳定性
J Bacteriol. 2004 May;186(10):3086-96. doi: 10.1128/JB.186.10.3086-3096.2004.
3
Escherichia coli O157:H7 Shiga toxin-encoding bacteriophages: integrations, excisions, truncations, and evolutionary implications.大肠杆菌O157:H7志贺毒素编码噬菌体:整合、切除、截短及进化意义
J Bacteriol. 2003 Jun;185(12):3596-605. doi: 10.1128/JB.185.12.3596-3605.2003.
4
Are quinolone-resistant uropathogenic Escherichia coli less virulent?耐喹诺酮的尿路致病性大肠杆菌毒力更低吗?
J Infect Dis. 2002 Oct 1;186(7):1039-42. doi: 10.1086/342955. Epub 2002 Sep 13.
5
A uropathogenicity island contributes to the pathogenicity of Escherichia coli strains that cause neonatal meningitis.一个泌尿道致病性岛有助于引起新生儿脑膜炎的大肠杆菌菌株的致病性。
Infect Immun. 2002 Oct;70(10):5865-9. doi: 10.1128/IAI.70.10.5865-5869.2002.
6
Relationship between haemolysis production and resistance to fluoroquinolones among clinical isolates of Escherichia coli.大肠杆菌临床分离株中溶血产生与对氟喹诺酮类药物耐药性之间的关系。
J Antimicrob Chemother. 1999 Feb;43(2):277-9. doi: 10.1093/jac/43.2.277.
7
Identification of sat, an autotransporter toxin produced by uropathogenic Escherichia coli.鉴定由尿路致病性大肠杆菌产生的自转运毒素sat
Mol Microbiol. 2000 Oct;38(1):53-66. doi: 10.1046/j.1365-2958.2000.02110.x.
8
Pathogenicity islands and the evolution of microbes.致病岛与微生物的进化
Annu Rev Microbiol. 2000;54:641-79. doi: 10.1146/annurev.micro.54.1.641.
9
Extended virulence genotypes of Escherichia coli strains from patients with urosepsis in relation to phylogeny and host compromise.与系统发育和宿主损害相关的尿路感染败血症患者大肠杆菌菌株的扩展毒力基因型
J Infect Dis. 2000 Jan;181(1):261-72. doi: 10.1086/315217.
10
Pathogenicity island sequences of pyelonephritogenic Escherichia coli CFT073 are associated with virulent uropathogenic strains.致肾盂肾炎大肠杆菌CFT073的致病岛序列与毒性尿路致病性菌株相关。
Infect Immun. 1997 Jul;65(7):2812-20. doi: 10.1128/iai.65.7.2812-2820.1997.

喹诺酮类药物分别通过SOS依赖或非依赖途径诱导尿路致病性大肠杆菌中致病岛部分或完全缺失。

Quinolones induce partial or total loss of pathogenicity islands in uropathogenic Escherichia coli by SOS-dependent or -independent pathways, respectively.

作者信息

Soto S M, Jimenez de Anta M T, Vila J

机构信息

Servei de Microbiología, Centre de Diagnostic Biomèdic, Hospital Clinic, IDIBAPS, Facultat de Medicina, Universitat de Barcelona, Barcelona, Spain.

出版信息

Antimicrob Agents Chemother. 2006 Feb;50(2):649-53. doi: 10.1128/AAC.50.2.649-653.2006.

DOI:10.1128/AAC.50.2.649-653.2006
PMID:16436722
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1366871/
Abstract

Escherichia coli is the most common microorganism causing urinary tract infections. Quinolone-resistant E. coli strains have fewer virulence factors than quinolone-susceptible strains. Several urovirulence genes are located in pathogenicity islands (PAIs). We investigated the capacity of quinolones to induce loss of virulence factors such as hemolysin, cytotoxic necrotizing factor 1, P fimbriae, and autotransporter Sat included in PAIs in three uropathogenic E. coli strains. In a multistep selection, all strains lost hemolytic capacity at between 1 and 4 passages when they were incubated with subinhibitory concentrations of ciprofloxacin, showing a partial or total loss of the PAI containing the hly (hemolysin) and cnf-1 (cytotoxic necrotizing factor 1) genes. RecA(-) mutants were obtained from the two E. coli strains with partial or total loss of the PAI. The inactivation of the RecA protein affected only the partial loss of the PAI induced by quinolones. No spontaneous loss of PAIs was observed on incubation in the absence of quinolones in either the wild-type or mutant E. coli strains. Quinolones induce partial or total loss of PAIs in vitro in uropathogenic E. coli by SOS-dependent or -independent pathways, respectively.

摘要

大肠杆菌是引起尿路感染最常见的微生物。耐喹诺酮的大肠杆菌菌株比喹诺酮敏感菌株的毒力因子更少。几种尿路毒力基因位于致病岛(PAIs)中。我们研究了喹诺酮类药物诱导三种尿路致病性大肠杆菌菌株中致病岛所含毒力因子(如溶血素、细胞毒性坏死因子1、P菌毛和自转运蛋白Sat)丧失的能力。在多步筛选中,当所有菌株与亚抑制浓度的环丙沙星孵育时,在1至4代之间均丧失了溶血能力,显示出含有hly(溶血素)和cnf-1(细胞毒性坏死因子1)基因的致病岛部分或全部丢失。从PAI部分或全部丢失的两种大肠杆菌菌株中获得了RecA(-)突变体。RecA蛋白的失活仅影响喹诺酮类药物诱导的PAI部分丢失。在野生型或突变型大肠杆菌菌株中,在无喹诺酮类药物孵育时均未观察到PAI的自发丢失。喹诺酮类药物分别通过SOS依赖或非依赖途径在体外诱导尿路致病性大肠杆菌中PAI的部分或全部丢失。